Vimarsana
Biggest News Aggregation in the World

Outstanding Effect News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Outstanding Effect. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Outstanding Effect Today - Breaking & Trending Today

NeuroSense Announces Third Quarter 2023 Financial Results and Provides Business Update - Vimarsana News

NeuroSense Announces Third Quarter 2023 Financial Results and Provides Business Update

Published: November 28, 2023

Topline clinical secondary efficacy results and primary safety endpoints from Phase 2b ALS trial expected in early December 2023Patients who completed the 18-month PARADIGM trial, including the...

Source: marketscreener.com
Related Topics:
United KingdomPrnewswire Neurosense Therapeutics LtdCompany PhaseDrug AdministrationExchange CommissionEuropean Medicines Agency Neurosense Opens Eu OfficeEuropean Medicines AgencyNeurosense Therapeutics LtdSense TherapeuticsAmyotrophic Lateral SclerosisCompleted Double Blind SegmentInvestigator Initiated TrialSlow Vital CapacityPrimec AheadPivotal PhaseSponsored Study Demonstrated PrimecOutstanding EffectIchida Stem Cell LabSouthern CaliforniaTrial Under PreparationFirst Patient Enrolled ExpectedValid ThroughNeurosense OpensMedium Sized EnterpriseOrphan Drug Designation
NeuroSense CEO Provides Q3 2023 Update - Vimarsana News

NeuroSense CEO Provides Q3 2023 Update

Published: October 17, 2023

Phase 2b ALS topline results expected December 2023 CAMBRIDGE, Mass., Oct. 17, 2023 /PRNewswire/ -- NeuroSense Therapeutics Ltd. , a company developing treatments for severe neurodegenerative...

Source: marketscreener.com
Related Topics:
United KingdomPrnewswire Neurosense Therapeutics LtdMarket Equity Offering ProgramEuropean Medicines Agency Opened OfficeExchange Commission OnExchange CommissionNeurosense Therapeutics LtdSense TherapeuticsAlon Ben NoonSponsored Study Demonstrated PrimecOutstanding EffectIchida Stem Cell LabSouthern CaliforniaEuropean Medicines AgencyOpened OfficeMedium Sized EnterpriseAt The Market Equity Offering ProgramNeurosense TherapeuticAnnual ReportNeurosense Therapeutics